RESEARCH AND DEVELOPMENT
2021-10-13LL
Responsive Innovation in Metastatic Breast Cancer Research
Voices from the Lab:<br>Nizar El-Murr on Immuno-Oncology
Our commitment to fight COVID-19
Throughout the ongoing pandemic, Sanofi has joined forces to fight COVID-19 in every way possible
Sanofi’s Rare Humanitarian Program Turns 30
“Our purpose is clear–to help ensure that people living with rare diseases around the world have the ability to access the treatments they need” -Paul Hudson, Chief Executive Officer
Join us!
You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives
-
Press releases2021-10-22MMMM DD YYYYDupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease